Paper36730630
Comprehensive Overview: The Effect of Using Different Solvents for Barley Extraction with Its Anti-Inflammatory and Antioxidant Activity.
Eid O and 4 others. Chem Biodivers, 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Comprehensive Overview: The Effect of Using Different Solvents for Barley Extraction with Its Anti-Inflammatory and Antioxidant Activity. Papers, record 36730630. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36730630
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comprehensive Overview: The Effect of Using Different Solvents for Barley Extraction with Its Anti-Inflammatory and Antioxidant Activity.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antioxidants | Major topic |
| Hordeum | Major topic |
| Anti-Inflammatory Agents | Major topic |
| Humans | |
| Phenols | |
| Solvents | |
| Vitamin E |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42014983 | Population and pangenome analyses uncover the evolutionary dynamics of the peroxidase gene family in barley. | BMC Genomics | 2026 | https://conductscience.org/library/papers/42014983 | PubMed |
| 41928669 | Synergistic Combinations of Natural and Synthetic Agents: A Novel Therapeutic Frontier in Breast Cancer Management. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/41928669 | PubMed |
| 41096250 | Molecular Properties of Starch-Water Interactions in the Presence of Bioactive Compounds from Barley and Buckwheat-LF NMR Preliminary Study. | Polymers (Basel) | 2025 | https://conductscience.org/library/papers/41096250 | PubMed |
| 41075026 | Beta-Glucan in barley as a natural immunomodulator: mechanisms and therapeutic potential. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/41075026 | PubMed |
| 40647956 | Integrated Metabolomics and Proteomics Analyses of the Grain-Filling Process and Differences in the Quality of Tibetan Hulless Barleys. | Plants (Basel) | 2025 | https://conductscience.org/library/papers/40647956 | PubMed |
| 38645372 | Development of Nanostructured Lipid Carrier-Loaded Flavonoid-Enriched Zingiber officinale. | ACS Omega | 2024 | https://conductscience.org/library/papers/38645372 | PubMed |
| 38509904 | Phytochemical analysis, GC-MS characterization and antioxidant activity of Hordeum vulgare seed extracts. | Heliyon | 2024 | https://conductscience.org/library/papers/38509904 | PubMed |
| 37111115 | Phytochemicals in Cancer Treatment and Cancer Prevention-Review on Epidemiological Data and Clinical Trials. | Nutrients | 2023 | https://conductscience.org/library/papers/37111115 | PubMed |
| 36969583 | Simultaneous quantitative analysis and in vitro anti-arthritic effects of five polyphenols from Terminalia chebula. | Front Physiol | 2023 | https://conductscience.org/library/papers/36969583 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36730630
GET https://conductscience.org/api/papers/v1/36730630/authors